Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Sean Tavtigian
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Physiology
Disorders
Concepts & Ideas
Procedures
Chemicals & Drugs
Genes & Molecular Sequences
Anatomy
Sign-in to see full Profile
Network (preview)
16
Goldgar, David
12
Teng, David
8
Couch, Fergus J.
8
Skolnick, Mark
8
Wong, AK
8
Deffenbaugh, Amie
8
Kamb, Alexander
7
Chenevix-Trench, Georgia
7
Spurdle, Amanda
6
Swensen, Jeff
6
Davis, T
6
Chen, Yuan
5
Cannon-Albright, Lisa
5
de Silva, Deepika
5
Neuhausen, Susan
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Sean Tavtigian (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Garritano Sonia; Gemignani Federica; Palmero Edenir Inez; Olivier Magali; Martel-Planche Ghyslaine; Le Calvez-Kelm Florence; Brugiéres Laurence; Vargas Fernando Regla; Brentani Ricardo Renzo; Ashton-Prolla Patricia; Landi Stefano; Tavtigian Sean V; Hainaut Pierre; Achatz Maria Isabel W
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.
Human mutation 2010;31(2):143-50.
-
2009: Tavtigian Sean V; Oefner Peter J; Babikyan Davit; Hartmann Anne; Healey Sue; Le Calvez-Kelm Florence; Lesueur Fabienne; Byrnes Graham B; Chuang Shu-Chun; Forey Nathalie; Feuchtinger Corinna; Gioia Lydie; Hall Janet; Hashibe Mia; Herte Barbara; McKay-Chopin Sandrine; Thomas Alun; Vallée Maxime P; Voegele Catherine; Webb Penelope M; Whiteman David C; Sangrajrang Suleeporn; Hopper John L; Southey Melissa C; Andrulis Irene L; John Esther M; Chenevix-Trench Georgia
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
American journal of human genetics 2009;85(4):427-46.
-
2009: Nguyen-Dumont Tú; Calvez-Kelm Florence Le; Forey Nathalie; McKay-Chopin Sandrine; Garritano Sonia; Gioia-Patricola Lydie; De Silva Deepika; Weigel Ron; Sangrajrang Suleeporn; Lesueur Fabienne; Tavtigian Sean V;
Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis.
Human mutation 2009;30(6):884-90.
-
2009: Arnold Sven; Buchanan Daniel D; Barker Melissa; Jaskowski Lesley; Walsh Michael D; Birney Genevieve; Woods Michael O; Hopper John L; Jenkins Mark A; Brown Melissa A; Tavtigian Sean V; Goldgar David E; Young Joanne P; Spurdle Amanda B
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.
Human mutation 2009;30(5):757-70.
-
2009: Garritano Sonia; Gemignani Federica; Voegele Catherine; Nguyen-Dumont Tú; Le Calvez-Kelm Florence; De Silva Deepika; Lesueur Fabienne; Landi Stefano; Tavtigian Sean V
Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus.
BMC genetics 2009;10():5.
-
2008: Cotton Richard G H; Auerbach Arleen D; Axton Myles; Barash Carol Isaacson; Berkovic Samuel F; Brookes Anthony J; Burn John; Cutting Garry; den Dunnen Johan T; Flicek Paul; Freimer Nelson; Greenblatt Marc S; Howard Heather J; Katz Michael; Macrae Finlay A; Maglott Donna; Möslein Gabriela; Povey Sue; Ramesar Rajkumar S; Richards Carolyn S; Seminara Daniela; Smith Timothy D; Sobrido María-Jesús; Solbakk Jan Helge; Tanzi Rudolph E; Tavtigian Sean V; Taylor Graham R; Utsunomiya Joji; Watson Michael
GENETICS. The Human Variome Project.
Science (New York, N.Y.) 2008;322(5903):861-2.
-
2008: Tavtigian Sean V; Byrnes Graham B; Goldgar David E; Thomas Alun
Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications.
Human mutation 2008;29(11):1342-54.
-
2008: Plon Sharon E; Eccles Diana M; Easton Douglas; Foulkes William D; Genuardi Maurizio; Greenblatt Marc S; Hogervorst Frans B L; Hoogerbrugge Nicoline; Spurdle Amanda B; Tavtigian Sean V;
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Human mutation 2008;29(11):1282-91.
-
2008: Tavtigian Sean V; Greenblatt Marc S; Lesueur Fabienne; Byrnes Graham B;
In silico analysis of missense substitutions using sequence-alignment based methods.
Human mutation 2008;29(11):1327-36.
-
2008: Tavtigian Sean V; Greenblatt Marc S; Goldgar David E; Boffetta Paolo;
Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group.
Human mutation 2008;29(11):1261-4.
-
2008: Tischkowitz Marc D; Yilmaz Ahmet; Chen Long Q; Karyadi Danielle M; Novak David; Kirchhoff Tomas; Hamel Nancy; Tavtigian Sean V; Kolb Suzanne; Bismar Tarek A; Aloyz Raquel; Nelson Peter S; Hood Lee; Narod Steven A; White Kirsten A; Ostrander Elaine A; Isaacs William B; Offit Kenneth; Cooney Kathleen A; Stanford Janet L; Foulkes William D
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.
Cancer letters 2008;270(1):173-80.
-
2008: Tischkowitz Marc; Hamel Nancy; Carvalho Marcelo A; Birrane Gabriel; Soni Aditi; van Beers Erik H; Joosse Simon A; Wong Nora; Novak David; Quenneville Louise A; Grist Scott A; Nederlof Petra M; Goldgar David E; Tavtigian Sean V; Monteiro Alvaro N; Ladias John A A; Foulkes William D
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
European journal of human genetics : EJHG 2008;16(7):820-32.
-
2008: Farrugia Daniel J; Agarwal Mukesh K; Pankratz Vernon S; Deffenbaugh Amie M; Pruss Dmitry; Frye Cynthia; Wadum Linda; Johnson Kiley; Mentlick Jennifer; Tavtigian Sean V; Goldgar David E; Couch Fergus J
Functional assays for classification of BRCA2 variants of uncertain significance.
Cancer research 2008;68(9):3523-31.
-
2008: Hammet Fleur; George Jessica; Tesoriero Andrea A; Jenkins Mark A; Schroen Christopher; Smith Letitia; Grabosch-Meehan Anke; Dite Gillian; McCredie Margaret R E; Giles Graham G; Tavtigian Sean V; Hopper John L; Southey Melissa C
Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?
Breast cancer research and treatment 2008;109(1):177-9.
-
2008: Spurdle Amanda B; Lakhani Sunil R; Healey Sue; Parry Suzanne; Da Silva Leonard M; Brinkworth Ross; Hopper John L; Brown Melissa A; Babikyan Davit; Chenevix-Trench Georgia; Tavtigian Sean V; Goldgar David E;
Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1657-63.
-
2007: Easton Douglas F; Deffenbaugh Amie M; Pruss Dmitry; Frye Cynthia; Wenstrup Richard J; Allen-Brady Kristina; Tavtigian Sean V; Monteiro Alvaro N A; Iversen Edwin S; Couch Fergus J; Goldgar David E
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
American journal of human genetics 2007;81(5):873-83.
-
2007: Voegele C; Tavtigian S V; de Silva D; Cuber S; Thomas A; Le Calvez-Kelm F
A Laboratory Information Management System (LIMS) for a high throughput genetic platform aimed at candidate gene mutation screening.
Bioinformatics (Oxford, England) 2007;23(18):2504-6.
-
2007: Petitjean Audrey; Mathe Ewy; Kato Shunsuke; Ishioka Chikashi; Tavtigian Sean V; Hainaut Pierre; Olivier Magali
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Human mutation 2007;28(6):622-9.
-
2007: Johnson Nichola; Fletcher Olivia; Palles Claire; Rudd Matthew; Webb Emily; Sellick Gabrielle; dos Santos Silva Isabel; McCormack Valerie; Gibson Lorna; Fraser Agnes; Leonard Angela; Gilham Clare; Tavtigian Sean V; Ashworth Alan; Houlston Richard; Peto Julian
Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility.
Human molecular genetics 2007;16(9):1051-7.
-
2007: Karchin Rachel; Monteiro Alvaro N A; Tavtigian Sean V; Carvalho Marcelo A; Sali Andrej
Functional impact of missense variants in BRCA1 predicted by supervised learning.
PLoS computational biology 2007;3(2):e26.
-
2007: Lovelock Paul K; Spurdle Amanda B; Mok Myth T S; Farrugia Daniel J; Lakhani Sunil R; Healey Sue; Arnold Stephen; Buchanan Daniel; Couch Fergus J; Henderson Beric R; Goldgar David E; Tavtigian Sean V; Chenevix-Trench Georgia; Brown Melissa A
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Breast cancer research : BCR 2007;9(6):R82.
-
2007: Cardis Elisabeth; Hall Janet; Tavtigian Sean V
Identification of women with an increased risk of developing radiation-induced breast cancer.
Breast cancer research : BCR 2007;9(3):106.
-
2006: Waddell Nic; Jonnalagadda Jyoti; Marsh Anna; Grist Scott; Jenkins Mark; Hobson Karen; Taylor Malcolm; Lindeman Geoff J; Tavtigian Sean V; Suthers Graeme; Goldgar David; Oefner Peter J; Taylor Darrin; Grimmond Sean; Khanna Kum Kum; Chenevix-Trench Georgia
Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
Genes, chromosomes & cancer 2006;45(12):1169-81.
-
2006: Sodha Nayanta; Mantoni Tine S; Tavtigian Sean V; Eeles Rosalind; Garrett Michelle D
Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation.
Cancer research 2006;66(18):8966-70.
-
2006: Tavtigian S V; Deffenbaugh A M; Yin L; Judkins T; Scholl T; Samollow P B; de Silva D; Zharkikh A; Thomas A
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.
Journal of medical genetics 2006;43(4):295-305.
-
2006: Chenevix-Trench Georgia; Healey Sue; Lakhani Sunil; Waring Paul; Cummings Margaret; Brinkworth Ross; Deffenbaugh Amie M; Burbidge Lynn Anne; Pruss Dmitry; Judkins Thad; Scholl Tom; Bekessy Anna; Marsh Anna; Lovelock Paul; Wong Ming; Tesoriero Andrea; Renard Helene; Southey Melissa; Hopper John L; Yannoukakos Koulis; Brown Melissa; Easton Douglas; Tavtigian Sean V; Goldgar David; Spurdle Amanda B;
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.
Cancer research 2006;66(4):2019-27.
-
2006: Lovelock P K; Healey S; Au W; Sum E Y M; Tesoriero A; Wong E M; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian S V; Goldgar D; Lindeman G J; Visvader J E; Couch F J; Henderson B R; Southey M; Chenevix-Trench G; Spurdle A B; Brown M A;
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
Journal of medical genetics 2006;43(1):74-83.
-
2006: Tavtigian Sean V; Pierotti Marco A; Børresen-Dale Anne-Lise
International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'.
Breast cancer research : BCR 2006;8(6):303.
-
2006: Durocher Francine; Labrie Yvan; Soucy Penny; Sinilnikova Olga; Labuda Damian; Bessette Paul; Chiquette Jocelyne; Laframboise Rachel; Lépine Jean; Lespérance Bernard; Ouellette Geneviève; Pichette Roxane; Plante Marie; Tavtigian Sean V; Simard Jacques
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
BMC cancer 2006;6():230.
-
2006: Tavtigian Sean V; Samollow Paul B; de Silva Deepika; Thomas Alun
An analysis of unclassified missense substitutions in human BRCA1.
Familial cancer 2006;5(1):77-88.
-
2006: Avard Denise; Bridge Peter; Bucci Lucie M; Chiquette Jocelyne; Dorval Michel; Durocher Francine; Easton Doug; Godard Béatrice; Goldgar David; Knoppers Bartha Maria; Laframboise Rachel; Lespérance Bernard; Plante Marie; Tavtigian Sean V; Vézina Hélène; Wilson Brenda; Simard Jacques
Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges.
Familial cancer 2006;5(1):3-13.
-
2006: Mathe Ewy; Olivier Magali; Kato Shunsuke; Ishioka Chikashi; Hainaut Pierre; Tavtigian Sean V
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods.
Nucleic acids research 2006;34(5):1317-25.
-
2005: Hung Rayjean J; van der Hel Olga; Tavtigian Sean V; Brennan Paul; Boffetta Paolo; Hashibe Mia
Perspectives on the molecular epidemiology of aerodigestive tract cancers.
Mutation research 2005;592(1-2):102-18.
-
2005: Al-Alem Umaima; Li Cuiling; Forey Nathalie; Relouzat Francis; Fondanèche Marie-Claude; Tavtigian Sean V; Wang Zhao-Qi; Latour Sylvain; Yin Luo
Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap.
Blood 2005;106(6):2069-75.
-
2005: Camp Nicola J; Swensen Jeff; Horne Benjamin D; Farnham James M; Thomas Alun; Cannon-Albright Lisa A; Tavtigian Sean V
Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer.
Genetic epidemiology 2005;28(3):232-43.
-
2005: Phelan C M; Dapic V; Tice B; Favis R; Kwan E; Barany F; Manoukian S; Radice P; van der Luijt R B; van Nesselrooij B P M; Chenevix-Trench G; kConFab; Caldes T; de la Hoya M; Lindquist S; Tavtigian S V; Goldgar D; Borg A; Narod S A; Monteiro A N A
Classification of BRCA1 missense variants of unknown clinical significance.
Journal of medical genetics 2005;42(2):138-46.
-
2005: Farnham James M; Camp Nicola J; Swensen Jeff; Tavtigian Sean V; Albright Lisa A Cannon
Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees.
Human genetics 2005;116(3):179-85.
-
2005: Wu Kangjian; Hinson Shannon R; Ohashi Akihiro; Farrugia Daniel; Wendt Patricia; Tavtigian Sean V; Deffenbaugh Amie; Goldgar David; Couch Fergus J
Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.
Cancer research 2005;65(2):417-26.
-
2005: Pettigrew Christopher; Wayte Nicola; Lovelock Paul K; Tavtigian Sean V; Chenevix-Trench Georgia; Spurdle Amanda B; Brown Melissa A
Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms.
Breast cancer research : BCR 2005;7(6):R929-39.
-
2005: Chen Yang; Beck Audrey; Davenport Christina; Chen Yuan; Shattuck Donna; Tavtigian Sean V
Characterization of TRZ1, a yeast homolog of the human candidate prostate cancer susceptibility gene ELAC2 encoding tRNase Z.
BMC molecular biology 2005;6(1):12.
-
2004: Goldgar David E; Easton Douglas F; Deffenbaugh Amie M; Monteiro Alvaro N A; Tavtigian Sean V; Couch Fergus J;
Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.
American journal of human genetics 2004;75(4):535-44.
-
2004: Dumont Martine; Frank David; Moisan Anne-Marie; Tranchant Martine; Soucy Penny; Breton Rock; Labrie Fernand; Tavtigian Sean V; Simard Jacques
Structure of primate and rodent orthologs of the prostate cancer susceptibility gene ELAC2.
Biochimica et biophysica acta 2004;1679(3):230-47.
-
2004: Abkevich V; Zharkikh A; Deffenbaugh A M; Frank D; Chen Y; Shattuck D; Skolnick M H; Gutin A; Tavtigian S V
Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.
Journal of medical genetics 2004;41(7):492-507.
-
2003: Simard J; Dumont M; Labuda D; Sinnett D; Meloche C; El-Alfy M; Berger L; Lees E; Labrie F; Tavtigian S V
Prostate cancer susceptibility genes: lessons learned and challenges posed.
Endocrine-related cancer 2003;10(2):225-59.
-
2003: Korver Wouter; Guevara Claudia; Chen Yang; Neuteboom Saskia; Bookstein Rob; Tavtigian Sean; Lees Emma
The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex.
International journal of cancer. Journal international du cancer 2003;104(3):283-8.
-
2002: Camp Nicola J; Tavtigian Sean V
Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.
American journal of human genetics 2002;71(6):1475-8.
-
2002: Frank Thomas S; Deffenbaugh Amie M; Reid Julia E; Hulick Mark; Ward Brian E; Lingenfelter Beth; Gumpper Kathi L; Scholl Thomas; Tavtigian Sean V; Pruss Dmitry R; Critchfield Gregory C
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1480-90.
-
2002: Fujiwara Hiromichi; Emi Mitsura; Nagai Hisaki; Nishimura Taiji; Konishi Noboru; Kubota Yoshinobu; Ichikawa Tomohiko; Takahashi Satoru; Shuin Taro; Habuchi Tomonori; Ogawa Osamu; Inoue Katsuki; Skolnick Mark H; Swensen Jeff; Camp Nicola J; Tavtigian Sean V
Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.
Journal of human genetics 2002;47(12):641-8.
-
2001: Eng C; Brody L C; Wagner T M; Devilee P; Vijg J; Szabo C; Tavtigian S V; Nathanson K L; Ostrander E; Frank T S;
Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.
Journal of medical genetics 2001;38(12):824-33.
-
2001: Teng D H; Chen Y; Lian L; Ha P C; Tavtigian S V; Wong A K
Mutation analyses of 268 candidate genes in human tumor cell lines.
Genomics 2001;74(3):352-64.
-
2000: Wong A K; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland A M; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian S V; Teng D H; Lees E
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.
Cancer research 2000;60(21):6171-7.
-
2000: Adey N B; Huang L; Ormonde P A; Baumgard M L; Pero R; Byreddy D V; Tavtigian S V; Bartel P L
Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.
Cancer research 2000;60(1):35-7.
-
1999: Neuhausen S L; Farnham J M; Kort E; Tavtigian S V; Skolnick M H; Cannon-Albright L A
Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees.
Human molecular genetics 1999;8(13):2437-42.
-
1999: Wong A K; Chen Y; Lian L; Ha P C; Petersen K; Laity K; Carillo A; Emerson M; Heichman K; Gupte J; Tavtigian S V; Teng D H
Genomic structure, chromosomal location, and mutation analysis of the human CDC14A gene.
Genomics 1999;59(2):248-51.
-
1999: Morimoto A M; Berson A E; Fujii G H; Teng D H; Tavtigian S V; Bookstein R; Steck P A; Bolen J B
Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase.
Oncogene 1999;18(6):1261-6.
-
1998: Wong A K; Ormonde P A; Pero R; Chen Y; Lian L; Salada G; Berry S; Lawrence Q; Dayananth P; Ha P; Tavtigian S V; Teng D H; Bartel P L
Characterization of a carboxy-terminal BRCA1 interacting protein.
Oncogene 1998;17(18):2279-85.
-
1998: Cheney I W; Johnson D E; Vaillancourt M T; Avanzini J; Morimoto A; Demers G W; Wills K N; Shabram P W; Bolen J B; Tavtigian S V; Bookstein R
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cancer research 1998;58(11):2331-4.
-
1998: Fults D; Pedone C A; Thompson G E; Uchiyama C M; Gumpper K L; Iliev D; Vinson V L; Tavtigian S V; Perry W L
Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
International journal of oncology 1998;12(4):905-10.
-
1997: Wong A K; Pero R; Ormonde P A; Tavtigian S V; Bartel P L
RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2.
The Journal of biological chemistry 1997;272(51):31941-4.
-
1997: Tsou H C; Teng D H; Ping X L; Brancolini V; Davis T; Hu R; Xie X X; Gruener A C; Schrager C A; Christiano A M; Eng C; Steck P; Ott J; Tavtigian S V; Peacocke M
The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases.
American journal of human genetics 1997;61(5):1036-43.
-
1997: Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian S V; Teng D H; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
JAMA : the journal of the American Medical Association 1997;278(15):1242-50.
-
1997: Teng D H; Perry W L; Hogan J K; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell J T; Pero R; Sexton D; Schroeder M; Su P H; Swedlund B; Kyriakis J M; Avruch J; Bartel P; Wong A K; Tavtigian S V
Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Cancer research 1997;57(19):4177-82.
-
1997: Hejlik D P; Kottickal L V; Liang H; Fairman J; Davis T; Janecki T; Sexton D; Perry W; Tavtigian S V; Teng D H; Nagarajan L
Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor.
Cancer research 1997;57(17):3779-83.
-
1997: Steck P A; Pershouse M A; Jasser S A; Yung W K; Lin H; Ligon A H; Langford L A; Baumgard M L; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng D H; Tavtigian S V
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nature genetics 1997;15(4):356-62.
-
1997: Skolnick M H; Frank T; Shattuck-Eidens D; Tavtigian S
Genetic susceptibility to breast and ovarian cancer.
Pathologie-biologie 1997;45(3):245-9.
-
1996: Teng D H; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha P C; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick M H; Tavtigian S V; Jhanwar S; Swedlund B; Wong A K; Kamb A
Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
Nature genetics 1996;13(2):241-4.
-
1996: Couch F J; Farid L M; DeShano M L; Tavtigian S V; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin A K; Daly M; Radford D M; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber B L
BRCA2 germline mutations in male breast cancer cases and breast cancer families.
Nature genetics 1996;13(1):123-5.
-
1996: Thorlacius S; Olafsdottir G; Tryggvadottir L; Neuhausen S; Jonasson J G; Tavtigian S V; Tulinius H; Ogmundsdottir H M; Eyfjörd J E
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
Nature genetics 1996;13(1):117-9.
-
1996: Tavtigian S V; Simard J; Rommens J; Couch F; Shattuck-Eidens D; Neuhausen S; Merajver S; Thorlacius S; Offit K; Stoppa-Lyonnet D; Belanger C; Bell R; Berry S; Bogden R; Chen Q; Davis T; Dumont M; Frye C; Hattier T; Jammulapati S; Janecki T; Jiang P; Kehrer R; Leblanc J F; Mitchell J T; McArthur-Morrison J; Nguyen K; Peng Y; Samson C; Schroeder M; Snyder S C; Steele L; Stringfellow M; Stroup C; Swedlund B; Swense J; Teng D; Thomas A; Tran T; Tranchant M; Weaver-Feldhaus J; Wong A K; Shizuya H; Eyfjord J E; Cannon-Albright L; Tranchant M; Labrie F; Skolnick M H; Weber B; Kamb A; Goldgar D E
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
Nature genetics 1996;12(3):333-7.
-
1995: Hattier T; Bell R; Shaffer D; Stone S; Phelps R S; Tavtigian S V; Skolnick M H; Shattuck-Eidens D; Kamb A
Monitoring the efficacy of hybrid selection during positional cloning: the search for BRCA1.
Mammalian genome : official journal of the International Mammalian Genome Society 1995;6(12):873-9.
-
1995: Stone S; Dayananth P; Jiang P; Weaver-Feldhaus J M; Tavtigian S V; Cannon-Albright L; Kamb A
Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.
Oncogene 1995;11(5):987-91.
-
1995: Stone S; Jiang P; Dayananth P; Tavtigian S V; Katcher H; Parry D; Peters G; Kamb A
Complex structure and regulation of the P16 (MTS1) locus.
Cancer research 1995;55(14):2988-94.
-
1994: Neuhausen S L; Swensen J; Miki Y; Liu Q; Tavtigian S; Shattuck-Eidens D; Kamb A; Hobbs M R; Gingrich J; Shizuya H
A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1.
Human molecular genetics 1994;3(11):1919-26.
-
1994: Futreal P A; Liu Q; Shattuck-Eidens D; Cochran C; Harshman K; Tavtigian S; Bennett L M; Haugen-Strano A; Swensen J; Miki Y
BRCA1 mutations in primary breast and ovarian carcinomas.
Science (New York, N.Y.) 1994;266(5182):120-2.
-
1994: Miki Y; Swensen J; Shattuck-Eidens D; Futreal P A; Harshman K; Tavtigian S; Liu Q; Cochran C; Bennett L M; Ding W
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Science (New York, N.Y.) 1994;266(5182):66-71.
-
1994: Kamb A; Futreal P A; Rosenthal J; Cochran C; Harshman K D; Liu Q; Phelps R S; Tavtigian S V; Tran T; Hussey C
Localization of the VHR phosphatase gene and its analysis as a candidate for BRCA1.
Genomics 1994;23(1):163-7.
-
1994: Kamb A; Gruis N A; Weaver-Feldhaus J; Liu Q; Harshman K; Tavtigian S V; Stockert E; Day R S; Johnson B E; Skolnick M H
A cell cycle regulator potentially involved in genesis of many tumor types.
Science (New York, N.Y.) 1994;264(5157):436-40.
Sign-in to see more
